sulfamerazine
Trade name: Neotrizine
Approved
Jun 1, 1943
Sulfamerazine is a sulfonamide antibiotic, which acts by inhibiting folic acid synthesis in bacterias. The primary target of sulfamerazine is believed to be dihydropteroate synthetase. Sulfamerazine (in comination with Sulfadiazine and Sulfamethazine) was used in the US under different names, including the earliest brand of Neotrizine. Nowdays, the drugs containing sulfamerazine are no longer available for use in humans in the US, however, they may be prescribed for veterinary purposes. — NCATS
Clinical trial activity
0 trials · 0 clinical orgs · 11 marketing orgs
Timeline
1940s
- Jun 1, 1943
Earliest FDA Approval
- Aug 16, 1949
Lederle — NDA Secondary Org
- Aug 16, 1949
American Cyanamid — NDA Secondary Org
1970s
- Jan 23, 1974
Impax Laboratories — Marketing Organization
- Jun 2, 1976
Alpharma — Marketing Organization
- Aug 24, 1978
Lannett Company, Inc. — Marketing Organization
Indications
Approved for
Mechanism of action
- Bacterial dihydropteroate synthaseINHIBITOR
folP inhibitor
Broad spectrum
Combination products
sulfonamides duplex
with sulfadiazine
trisulfapyrimidines
with sulfamethazine, sulfadiazine
Approval history
- approvedJun 1, 1943
Chemistry & pharmacology
SMILES
CC1=NC(NS(=O)(=O)C2=CC=C(N)C=C2)=NC=C1- Mol. weight
- 264.304 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
- Delivery
- Oral
- Availability
- Discontinued
Oral
Yes
Parenteral
No
Topical
No
Sources
- WikipediaSulfamerazine ↗
- NCATSUR1SAB295F ↗
- ChEMBLCHEMBL438 ↗
Also known as
- 2-(p-aminobenzolsulfonamido)-4-methylpyrimidine
- 2-(p-aminobenzolsulfonamido)-4-methylpyrimidine
- 2-sulfa-4-methylpyrimidine
- 2-sulfa-4-methylpyrimidine
- 2-(sulfanilamido)-4-methylpyrimidine
- 2-(sulfanilamido)-4-methylpyrimidine
- 4-amino-n-(4-methyl-2-pyrimidinyl)-benzenesulfonamide
- 4-amino-n-(4-methyl-2-pyrimidinyl)-benzenesulfonamide
- cremomerazine
- mesulfa
- mesulfa
- methylsulfazine
- methypyrimal
- metilsulfadiazin
- n-(4-methyl-2-pyrimidyl)sulfanilamide
- n-(4-methyl-2-pyrimidyl)sulfanilamide
- (p-aminobenzolsulfonyl)-2-amino-4-methylpyrimidin
- (p-aminobenzolsulfonyl)-2-amino-4-methylpyrimidin
- sulfamerazin
- sulfamerazina
- sulfamerazina
- sulfamerazine
- sulfamerazine
- sulfamerazine
- sulfamerazine
- sulfamerazine
- sulfamerazine
- sulfamerazine
- sulfamerazine
- sulfamerazine
- sulfamerazine (trisulfapyrimidines)
- sulfamerazine (trisulfapyrimidines)
- sulfamerazinum
- sulfamerazinum
- sulfamethyldiazine
- sulfamethyldiazine
- sulfamethyldiazine
- sulphamerazine
- sulphamerazine
- sulphamerazine
- sumedin
Organizations
Marketing (12)
| Organization | Org type | Relationship | Date |
|---|---|---|---|
| Alpharma | For profit | MKTG | Jun 2, 1976 |
| American Cyanamid | For profit | NDA2 | Aug 16, 1949 |
| American Home Products | For profit | MKTG | — |
| Bristol-Myers Squibb | For profit | NDA2 | — |
| Eli Lilly | For profit | NDA2 | — |
| Forest Laboratories | For profit | MKTG | — |
| Impax Laboratories | For profit | MKTG | Jan 23, 1974 |
| Lannett Company, Inc. | For profit | MKTG | Aug 24, 1978 |
| Lannett Company, Inc. | For profit | SYN | Jun 12, 1975 |
| Lederle | For profit | NDA2 | Aug 16, 1949 |
| Puracap Pharmaceutical | For profit | MKTG | — |
| Sharp & Dohme | For profit | NDA | — |